ALDX
Price
$5.03
Change
-$0.38 (-7.02%)
Updated
Feb 4, 02:20 PM (EDT)
Capitalization
326.08M
36 days until earnings call
Intraday BUY SELL Signals
CMVLF
Price
$2.60
Change
-$0.52 (-16.67%)
Updated
Sep 2 closing price
Capitalization
388.82M
Intraday BUY SELL Signals
Interact to see
Advertisement

ALDX vs CMVLF

Header iconALDX vs CMVLF Comparison
Open Charts ALDX vs CMVLFBanner chart's image
Aldeyra Therapeutics
Price$5.03
Change-$0.38 (-7.02%)
Volume$100
Capitalization326.08M
Cellectis Romainville
Price$2.60
Change-$0.52 (-16.67%)
Volume$160
Capitalization388.82M
ALDX vs CMVLF Comparison Chart in %
ALDX
Daily Signal:
Gain/Loss:
CMVLF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALDX vs. CMVLF commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Buy and CMVLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (ALDX: $5.41 vs. CMVLF: $4.40)
Brand notoriety: ALDX and CMVLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 47% vs. CMVLF: 20%
Market capitalization -- ALDX: $326.08M vs. CMVLF: $388.82M
ALDX [@Biotechnology] is valued at $326.08M. CMVLF’s [@Biotechnology] market capitalization is $388.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileCMVLF’s FA Score has 0 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • CMVLF’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALDX and CMVLF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 5 TA indicator(s) are bullish while CMVLF’s TA Score has 2 bullish TA indicator(s).

  • ALDX’s TA Score: 5 bullish, 4 bearish.
  • CMVLF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, ALDX is a better buy in the short-term than CMVLF.

Price Growth

ALDX (@Biotechnology) experienced а -2.35% price change this week, while CMVLF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

ALDX is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMVLF($389M) has a higher market cap than ALDX($326M). ALDX YTD gains are higher at: 4.440 vs. CMVLF (0.000). CMVLF has higher annual earnings (EBITDA): -6.07M vs. ALDX (-41.04M). CMVLF has more cash in the bank: 190M vs. ALDX (75.3M). ALDX has less debt than CMVLF: ALDX (15.5M) vs CMVLF (92.8M). CMVLF has higher revenues than ALDX: CMVLF (75.3M) vs ALDX (0).
ALDXCMVLFALDX / CMVLF
Capitalization326M389M84%
EBITDA-41.04M-6.07M676%
Gain YTD4.4400.000-
P/E RatioN/AN/A-
Revenue075.3M-
Total Cash75.3M190M40%
Total Debt15.5M92.8M17%
FUNDAMENTALS RATINGS
ALDX vs CMVLF: Fundamental Ratings
ALDX
CMVLF
OUTLOOK RATING
1..100
1540
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
4838
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
377

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMVLF's Valuation (34) in the null industry is in the same range as ALDX (41) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to ALDX’s over the last 12 months.

CMVLF's Profit vs Risk Rating (100) in the null industry is in the same range as ALDX (100) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to ALDX’s over the last 12 months.

CMVLF's SMR Rating (96) in the null industry is in the same range as ALDX (98) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to ALDX’s over the last 12 months.

CMVLF's Price Growth Rating (38) in the null industry is in the same range as ALDX (48) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to ALDX’s over the last 12 months.

CMVLF's P/E Growth Rating (100) in the null industry is in the same range as ALDX (100) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to ALDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXCMVLF
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
49%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
46%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
26%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
23%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
79%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
ALDX
Daily Signal:
Gain/Loss:
CMVLF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LODFF0.390.03
+7.82%
Lode Gold Resources Inc.
RMGGY5.70N/A
N/A
Resolute Mining Ltd.
SOME68.00N/A
N/A
Somerset Trust Holding Co.
ATEYY161.93-0.92
-0.56%
Advantest Corp.
BLSFF20.52-0.48
-2.29%
Bluescope Steel, Ltd.

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with CANF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-0.37%
CANF - ALDX
46%
Loosely correlated
-1.94%
CMVLF - ALDX
39%
Loosely correlated
N/A
CLLS - ALDX
39%
Loosely correlated
-7.59%
PLRX - ALDX
38%
Loosely correlated
+1.68%
ARVN - ALDX
37%
Loosely correlated
-1.30%
More

CMVLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMVLF has been closely correlated with CLLS. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if CMVLF jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMVLF
1D Price
Change %
CMVLF100%
N/A
CLLS - CMVLF
78%
Closely correlated
-7.59%
SLN - CMVLF
41%
Loosely correlated
-1.22%
ALDX - CMVLF
39%
Loosely correlated
-0.37%
CLGN - CMVLF
37%
Loosely correlated
-8.70%
ASPHF - CMVLF
36%
Loosely correlated
N/A
More